BiomX Inc.

11/29/2023 | Press release | Distributed by Public on 11/29/2023 05:32

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis